However, the results highlighted in our study and our meta-analyses of existing datasets showed increased S100A14 expression in tumor lesions associated with the serrated pathway compared to tumors arising from the conventional adenoma–carcinoma sequence. This evidence concerns the gene S100A14 and adenoma.